Switching to Mounjaro for medical weight loss: benefits and precautions explained by a doctor

  • Published:
  • Updated:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 50 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Switching to Mounjaro for medical weight loss: benefits and precautions explained by a doctor

In recent years, medical weight loss using Mounjaro has been attracting attention in obesity treatment. Mounjaro offers a new option for weight management that was difficult to achieve with diet and exercise alone. This article explains, based on evidence, everything from how Mounjaro works to examples of its use in clinical practice, its impact on patients, and changes in medical settings.

Key points firstShort on time? Just read this

  • Mounjaro is a once-weekly injectable medical weight-loss drug that acts on both GLP-1 and GIP; in Japan it is approved as a treatment for type 2 diabetes
  • Clinical trials have shown that Mounjaro can achieve substantial weight loss that was difficult with diet and exercise alone
  • Most of Mounjaro’s side effects are digestive symptoms, which may be reduced by starting at a low dose and taking it after meals

1. What is Mounjaro?

Mounjaro is a once-weekly injectable medical weight-loss drug that acts on both GLP-1 and GIP; in Japan it is approved as a treatment for type 2 diabetes. Use for weight loss is self-pay treatment at a doctor’s discretion, so first make sure you understand where this drug stands.

Mounjaro is a “dual GIP/GLP-1 receptor agonist” that acts on the receptors for both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide), and was originally developed as a treatment for type 2 diabetes. GLP-1 and GIP are both hormones released from the intestine; in addition to curbing the rise in blood sugar after meals, they increase the feeling of fullness. Applying this dual action, high effectiveness has also been reported in obesity treatment, and it is attracting attention as a medical weight-loss drug that promotes weight loss. Note that in Japan, Mounjaro is approved as a treatment for type 2 diabetes, and use for weight loss is self-pay treatment (off-label use) at a doctor’s discretion.

  • Overview of how it works
    1. Appetite suppression: acts on the satiety center in the brain to reduce appetite.
    2. Delayed gastric emptying: slows the emptying of stomach contents after meals, prolonging the feeling of fullness.
    3. Blood sugar regulation: promotes insulin secretion from pancreatic beta cells and suppresses glucagon secretion from alpha cells.

Source: Jastreboff AM et al. N Engl J Med. 2022;387:205-216. (SURMOUNT-1 trial)

2. Clinical effects of Mounjaro in medical weight loss

Clinical trials have shown that Mounjaro can achieve substantial weight loss that was difficult with diet and exercise alone. Secondary effects beyond weight loss have also been reported, such as improvements in blood pressure, HbA1c and lipid profile.

Clinical trials have shown that Mounjaro can achieve weight loss that is hard to reach with conventional lifestyle changes alone.

  • SURMOUNT trial series
    In SURMOUNT-1, an international multicenter trial of Mounjaro (tirzepatide), average weight loss after 72 weeks of treatment reached about 15–22.5% depending on the dose. A tendency for greater weight loss at higher doses was observed.
  • Secondary effects
    • Lower blood pressure
    • Improved HbA1c
    • Improved dyslipidemia

It has been reported that these effects also reduce the risk of lifestyle-related diseases associated with obesity.

Source: Jastreboff AM et al., N Engl J Med. 2022;387:205-216. (SURMOUNT-1 trial)

3. Changes in medical settings

The introduction of Mounjaro is changing not only patient behavior but also the role of healthcare professionals and the way treatment plans are made. Medical weight loss is broadening from “leaving it up to self-management” to “a support system that works alongside drug management.”

The introduction of Mounjaro has brought several changes to medical weight-loss practice.

3-1. Changes in patient behavior

Traditionally, medical weight loss centered on self-management and relied heavily on exercise and dietary restriction, and many patients gave up. With Mounjaro, however, patients feel full more easily, so they can naturally adjust how much they eat, and their motivation to improve their lifestyle increases.

3-2. Changes in the role of healthcare professionals

The involvement of doctors and registered dietitians is shifting beyond simply giving dietary guidance and making exercise plans, toward managing the appropriate dose of Mounjaro and following up on side effects. This strengthens ongoing support for patients and increases the likelihood of maintaining weight loss over the long term.

3-3. Personalized treatment plans

Mounjaro has made it possible to tailor medical weight loss to each patient’s build, medical history and lifestyle. Previously, treatment centered on “one-size-fits-all dietary restriction and exercise therapy,” but combining it with the effects of a drug allows more flexible treatment plans.

4. Precautions when using Mounjaro

Mounjaro must be used under a doctor’s supervision; starting at a low dose and increasing gradually is the basis of safe use. If you have reduced kidney function or a history of digestive disease, be sure to tell your doctor before starting.

Mounjaro must be used under a doctor’s supervision. The following common side effects have been reported.

  • Nausea, vomiting, diarrhea
  • Risk of nutritional deficiency due to reduced appetite
  • Rare risk of pancreatitis or gallstones

Careful management is required especially in patients with reduced kidney function or a history of digestive disease. It is also recommended to start at a low dose at the beginning of treatment and increase it step by step according to changes in your condition.

Source: Jastreboff AM et al., 2022 (SURMOUNT-1 trial, including safety data)

5. Success stories from medical weight-loss practice

In weight-loss programs using Mounjaro, results reportedly tend to depend on combining it with exercise and lifestyle guidance rather than using the drug alone. Because effects vary from person to person, ongoing consultation with your doctor is essential.

Weight-loss programs using Mounjaro have been introduced at medical institutions in Japan and abroad, and the following trends have been reported from clinical trials and clinical practice.

  • Improvements in weight and metabolic markers
    In patients who continued Mounjaro and lifestyle improvements under a doctor’s supervision, a tendency for weight loss along with improvement in blood sugar control markers over a period of months has been reported. However, effects vary from person to person, and the same results do not apply to everyone.
  • Effects of combining with exercise therapy
    Patients who combined Mounjaro with aerobic exercise are said to tend to notice changes in weight and waist circumference more easily than with the drug alone.

These trends show that the key to successful weight loss is not Mounjaro alone, but combining it with individual guidance from healthcare professionals and exercise therapy. For individual cases and specific figures, always consult your doctor.

Image of a patient consulting a doctor about switching to Mounjaro for medical weight loss

6. Future outlook

Medical weight loss centered on Mounjaro is expected to develop further through research on remote monitoring and combination drug therapy. In the future, it is also expected to be used for early intervention aimed at preventing disease.

Medical weight loss centered on Mounjaro is expected to evolve further.

  1. Use of remote monitoring
    Patients track their weight and meals in an app, and doctors give feedback online. This allows effective treatment support even at a distance.
  2. Research on combination drug therapy
    Research is under way on combining Mounjaro with other obesity drugs to enhance effects and reduce side effects.
  3. Preventive medical weight loss
    Strategies of early intervention while BMI is not yet high are expected to reduce the risk of developing diabetes and high blood pressure.

Source: Aronne LJ et al., JAMA. 2024;331(1):38-48. (SURMOUNT-4 trial, findings on continued treatment)

Summary so far

To sum up, the introduction of Mounjaro is changing medical weight loss through both changes in patient behavior and changes in the role of healthcare professionals. Balancing appropriate, evidence-based use of the drug with lifestyle improvements is a prerequisite for success.

The introduction of Mounjaro has brought the following changes to medical weight-loss practice.

  • Patients can naturally adjust how much they eat, and their motivation to improve their lifestyle increases
  • The role of healthcare professionals shifts from simple guidance to drug management and side-effect follow-up
  • Personalized treatment plans become possible, improving weight-loss success rates

Combining appropriate, evidence-based use of the drug with lifestyle improvements is essential to successful medical weight loss. Mounjaro is not just a weight-loss drug; it has become an important tool supporting “next-generation medical weight loss,” in which patients and healthcare professionals work together.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

7. Organizational changes in medical settings with Mounjaro

The introduction of Mounjaro is increasing the importance not only of care for individual patients but also of multidisciplinary collaboration among doctors, pharmacists, nurses and registered dietitians. The clinical workflow, from the initial assessment to long-term maintenance, is also becoming more precise and personalized.

The introduction of Mounjaro affects not only treatment outcomes for individual patients but also the operation of medical settings as a whole.

7-1. Growing importance of multidisciplinary collaboration

In conventional obesity treatment, collaboration centered on doctors and dietitians, but the use of Mounjaro has strengthened collaboration among the following professionals.

  • Pharmacists: explain side effects to patients and check other medications being taken.
  • Nurses: monitor changes in patients’ condition and loss of appetite.
  • Registered dietitians: adjust meal amounts and manage nutritional balance while on Mounjaro.

This ongoing support from a multidisciplinary team provides an environment in which patients can manage their weight safely and efficiently.

7-2. Optimizing the clinical workflow

After starting Mounjaro, initial effects on weight are usually seen in about 2–4 weeks. For this reason, the following workflow has become common in clinical practice.

  1. Initial assessment: measure BMI, blood pressure, blood sugar and lipid profile; ask about lifestyle habits.
  2. Starting treatment: start at a low dose and increase it in steps of weeks.
  3. Follow-up: assess changes in weight, appetite, digestive symptoms and side effects.
  4. Mid-term assessment: assess the rate of weight loss and metabolic markers at 3–6 months.
  5. Long-term maintenance: continued guidance on lifestyle improvements and dose adjustment as needed.

In this way, the introduction of Mounjaro tends to make the clinical workflow more precise and personalized.

8. Psychological changes seen in patients using Mounjaro

The sustained feeling of fullness with Mounjaro tends to ease the stress of dietary restriction and can also boost patients’ sense of self-efficacy. It is also worth noting that a lighter psychological burden makes it easier to keep up lifestyle improvements.

In medical weight loss, psychological factors strongly influence whether weight loss succeeds. Mounjaro has been reported to have not only an appetite-suppressing effect but also the following psychological effects.

  • Reassurance in controlling meals thanks to feeling full
    Even when eating less, hunger does not become strong, so there is less stress.
  • Greater self-efficacy from experiencing successful weight loss
    Losing weight increases motivation for exercise and lifestyle improvements.
  • A greater sense of social acceptance from changes in body shape
    Changes in appearance with weight loss improve self-esteem and satisfaction with relationships.

It has also been confirmed in clinical practice that a lighter psychological burden makes it easier for patients to keep up lifestyle improvements, raising the overall success rate of medical weight loss.

9. Safety and dealing with side effects

Most of Mounjaro’s side effects are digestive symptoms, which may be reduced by starting at a low dose and taking it after meals. If you have kidney impairment or a history of pancreatitis, a careful risk assessment before starting is essential.

While Mounjaro is highly effective, side effects must be handled appropriately. The following points are especially important.

  • Digestive symptoms
    Nausea and diarrhea are reported early on, but they often ease gradually and can be prevented by starting at a low dose and taking it after meals.
  • Nutrition management
    To prevent nutritional deficiency due to reduced appetite, it may be necessary to adjust what you eat or use supplements.
  • Careful use in patients with chronic diseases
    If you have kidney impairment or a history of pancreatitis, a risk assessment by a doctor before starting is essential.

By taking these measures, Mounjaro can be used safely for effective weight management.

10. The future of medical weight loss with Mounjaro

In the future, personalized medicine using genetic and gut bacteria analysis, and integration with telemedicine, are expected to advance. Mounjaro’s role may broaden from simply a weight-loss drug to a core tool of medical weight loss aimed at extending healthy life expectancy.

Medical weight loss centered on Mounjaro is expected to evolve in the following directions.

  1. Deeper personalized medicine
    Optimizing doses and lifestyle guidance according to each person’s metabolic characteristics, using genetic and gut bacteria analysis.
  2. Integration with telemedicine
    Monitoring weight and meals with wearable devices and apps, and online consultations with doctors and dietitians.
  3. Use as preventive medicine
    Early intervention when obesity risk is high is expected to help prevent lifestyle-related diseases such as diabetes and high blood pressure.

These changes have the potential to transform medical weight loss from merely a means of “losing weight” into a strategy for extending healthy life expectancy.

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

Q&A: frequently asked questions about switching to Mounjaro

Here are questions we often hear in consultations from people considering switching to Mounjaro. Answers may differ depending on individual symptoms and constitution, so please ask about any concerns directly during your consultation.

QIs there anything to watch out for when switching to Mounjaro from another GLP-1 drug?
A

The starting dose may be set differently depending on the action of the drug you were taking and how used to it your body has become. Do not switch on your own judgment; always see a doctor first and switch gradually while monitoring your condition.

QCan side effects be strong right after switching?
A

Until your body gets used to the new drug, digestive symptoms such as nausea and stomach discomfort may temporarily be stronger. In most cases they ease within a few days to about 2 weeks, but if symptoms continue, consult your doctor.

QIs switching to Mounjaro covered by health insurance?
A

Unless you have been diagnosed with type 2 diabetes, using Mounjaro to treat obesity is self-pay treatment (paid out of pocket). Always check the cost with the medical institution before signing up.

QHow soon after switching will I notice an effect?
A

Results vary, but many people are said to start noticing changes in weight or appetite about 2–4 weeks after starting. Because effects differ from person to person, it is important not to rush and to check your progress with your doctor.

QCan it be combined with other medications?
A

Depending on your medical history and the medications you are taking, care may be needed when combining them. In particular, if you have a history of pancreatitis or thyroid tumors, or are receiving other hormone-related treatment, be sure to tell your doctor in advance.

Summary

Medical weight loss with Mounjaro is a treatment option whose effects are maximized not by the drug alone but by working together with healthcare professionals. Please consider it in consultation with a doctor, understanding that it is self-pay treatment and that effects and side effects vary from person to person.

Medical weight loss with Mounjaro goes beyond the scope of a simple weight-loss drug and is bringing change to both medical settings and patients.

  • Patients can naturally adjust how much they eat thanks to a sustained feeling of fullness, easing the psychological burden.
  • Healthcare professionals can provide more precise weight-loss support through drug management, side-effect follow-up and multidisciplinary collaboration.
  • Clinical workflows and treatment plans become personalized, promoting long-term weight maintenance and lifestyle improvement.

In the future, personalized medicine combining genetic information and gut environment analysis, and the use of remote monitoring, will advance, and medical weight loss centered on Mounjaro will likely evolve even further.

References

  1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216. (SURMOUNT-1 trial)
    https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
  2. Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38-48.
    https://doi.org/10.1001/jama.2023.24945
  3. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. (SURPASS-2 trial)
    https://pubmed.ncbi.nlm.nih.gov/34170647/
  4. American Diabetes Association. Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl. 1):S1–S291.
    https://diabetesjournals.org/care/issue/46/Supplement_1

Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine)

Who to contact if you have side effects | When to seek medical care

If you have any of the following symptoms, contact us rather than waiting to see what happens. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly digestive symptoms. Most are mild, but serious ones occasionally occur.

SymptomPossible causeWhat to do
Ongoing nausea or vomitingDigestive symptoms; the most common side effectContact us if you remain unable to keep fluids down
Severe abdominal pain (pain that spreads to the back)Possible acute pancreatitisStop the injections immediately and seek medical care
Cold sweat, palpitations, strong hunger, feeling confused or drowsyHypoglycemiaTake sugar immediately and contact us
Skin rash, difficulty breathing, swelling of the face or throatAllergic reactionSeek medical care immediately

Contact: 0120-241-929 (9:00–18:00)
If your symptoms are severe outside these hours, go to your nearest emergency medical facility.

Direct phone numbers for each clinic are listed on the clinic information page.

References

The information about medicines in this article is based on the following official sources. For details on dosage, administration and side effects, always check the latest package insert.
Pharmaceuticals and Medical Devices Agency (PMDA), “Mounjaro Subcutaneous Injection Ateos: package insert” (Japanese)
PMDA, “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF, Japanese)
Ministry of Health, Labour and Welfare, “Prevention of lifestyle-related diseases” (Japanese)

Using Mounjaro for purposes other than obesity disease is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine About our medical review and editorial policy

You may also like

Back to all articles

Ask our AI chat AI chat